• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

New Year: New Insurance Authorizations for PAH Medications

December 16, 2014 By Dr. Jeremy Feldman

As we bring 2014 to an end and ring in the start of 2015 take a quick break from family, friends, and festivities to double check the authorizations of your PAH medications.

PAH New YearHow do I know if my PAH medication needs a new authorization?

Many insurance plans change their drug formularies each year. These changes can affect the quantity or strength of medications they are willing to pay for, change requirements a patient must meet to qualify for the medication to be authorized, or add or delete medications from their formulary. Each plan member will receive a written letter explaining these changes. Often times the letter will lay out which if any of the medications a patient is on have had any changes and outline the steps necessary to continue to receive the PAH therapy.

The New Year is also a popular time to switch insurance plans or pharmacy benefit plans. Most PH medications require prior authorizations. Double check your new plan formulary to see which of your medications will require a medication prior authorization.

How do I obtain a new prior authorization for my PH therapy?

PH Nurse Coordinator working on authorizationInsurance companies require that physicians’ offices complete medication prior authorization requests. The pulmonary hypertension nurse coordinator at your PH specialist’s office will need to submit a request for prior authorization via phone or faxed form. It is important for patients to provide new insurance and pharmacy benefit information including name of plan and ID number as soon as it is available as this information is necessary to complete the authorization process. The insurance company will respond to the physician via fax and plan member via mailed letter once a decision regarding the authorization has been made.

I have a new prior authorization for my PH treatment…now what?

Once the medication prior authorization has been approved by the insurance plan pharmacies will be able to fill the prescription. Contact the pulmonary hypertension nurse coordinator immediately if there are still problems obtaining the medication or if the copay is excessively high. The nurse coordinator can work behind the scenes to smooth out any problems and make sure the patient receives medication.

Each new PAH medication authorization will have an expiration date. Some approvals are good for 6 months, others 12 months, and some very rare plans indefinitely. Mark the expiration date on a calendar. A few weeks prior to the expiration contact the prescribing physician’s office and notify them that the expiration is approaching. This approach will allow for a new authorization to be obtained before any doses of medication have been missed.

Filed Under: Home Page, Living with PAH, Pulmonary Hypertension Treatments

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

PH related to lung disease

FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers

By Dr. Jeremy Feldman

Your Questions Answered Causes of Pulmonary Hypertension We received a variety of questions about the causes of

pulmonary hypertension research laboratory

Pulmonary Arterial Hypertension Research

By Dr. Jeremy Feldman

FDA Approval Process for PAH Drugs The past decade has seen many new drugs approved to treat PAH.  The development of a

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives